Insider Stock Trading History of Quimi Daphne


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Quimi Daphne since year 2005. The trader's CIK number is 1543031. At the time of this reporting, Quimi Daphne is the SVP, Finance of Amicus Therapeutics Inc . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Quimi Daphne since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-02 FOLD Amicus Therapeutics Inc Option Ex 8,000 14.71 117,720
2018-01-02 FOLD Amicus Therapeutics Inc Sale 8,000 14.71 117,720
2017-10-12 FOLD Amicus Therapeutics Inc Option Ex 7,000 14.25 99,743
2017-10-12 FOLD Amicus Therapeutics Inc Sale 7,000 14.25 99,743
2016-11-09 FOLD Amicus Therapeutics Inc Sale 8,546 8.00 68,368
2016-11-09 FOLD Amicus Therapeutics Inc Option Ex 2,858 8.00 22,864
2016-01-04 FOLD Amicus Therapeutics Inc Option Ex 25,000 .00 0
2015-10-01 FOLD Amicus Therapeutics Inc Option Ex 11,250 13.13 147,757
2015-10-01 FOLD Amicus Therapeutics Inc Sale 11,250 13.13 147,757
2015-09-14 FOLD Amicus Therapeutics Inc Sale 2,500 18.08 45,199
2015-07-01 FOLD Amicus Therapeutics Inc Option Ex 2,600 13.98 36,350
2015-07-01 FOLD Amicus Therapeutics Inc Sale 2,600 13.98 36,350
2015-05-08 FOLD Amicus Therapeutics Inc Option Ex 25,000 .00 0
2015-05-11 FOLD Amicus Therapeutics Inc Sale 7,500 10.84 81,307
2014-11-25 FOLD Amicus Therapeutics Inc Sale 3,500 8.00 28,000
2014-11-25 FOLD Amicus Therapeutics Inc Buy 3,500 8.00 28,000
2014-10-03 FOLD Amicus Therapeutics Inc Buy 6,812 7.00 47,684
2014-10-03 FOLD Amicus Therapeutics Inc Sale 6,812 7.00 47,684
2014-09-29 FOLD Amicus Therapeutics Inc Buy 10,738 6.10 65,469
2014-09-29 FOLD Amicus Therapeutics Inc Sale 10,738 6.10 65,469

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quimi Daphne (SVP, Finance of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.